多基因学为梅罗和托布拉米对抗超变性Pseudomonas aeruginosa的数学模型提供了信息
J R Tait1, A A Agyeman2, C López-Causapé3
1Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia; Centre for Medicine Use and Safety, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
International journal of antimicrobial agents
|March 8, 2025
概括
这项研究使用空洞纤维模型和多组学来了解Pseudomonas aeruginosa如何发展抗生素耐药性. 数学建模揭示了两种单独物种中明显的耐药机制,为个性化抗生素治疗铺平了道路.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
背景情况:
- 过度变异的Pseudomonas aeruginosa分离物在治疗期间经常会产生抗生素耐药性.
- 了解耐药机制对于有效治疗至关重要,特别是在囊性纤维化患者中.
- 目前选择抗生素方案的方法有局限性.
研究的目的:
- 通过使用动态空心纤维研究和基于多组学的数学建模,研究超变性Pseudomonas aeruginosa的耐药性出现.
- 模拟肺液中的抗生素度-时间概况,并观察细菌反应.
- 为了比较两种不同的P. aeruginosa分离物在美罗和托布拉米辛治疗下的耐药性机制.
主要方法:
- 两种超变性,异阻性P. aeruginosa分离物 (CW8和CW44) 被暴露在模拟的肺液度-时间形状的美罗和托布拉米中.
- 在细菌样本上进行了全基因组测序和种群转录组学.
- 多种组学数据为细菌种群的基于机制的数学建模提供了信息.
主要成果:
- 这两种隔离物都产生了耐药性,但高剂量组合疗法在CW8中协同抑制了长达96小时的耐药性再生.
- 隔离物之间出现的突变不同,影响了pmrB,ampR和PBP2.2等基因.
- 转录组分析揭示了基因表达的差异,包括CW8中mexB,oprM和ftsZ的下调,以及norspermidine基因的上调,表明了适应性抵抗机制.
结论:
- 多基因组数据成功告知了基于机制的建模,同时描述了两种P. aeruginosa分离物的细菌反应.
- 这种综合方法为了解复杂的抗生素耐药性动态提供了强大的工具.
- 这些发现突显了基于多组学信息的数学建模的潜力,以指导个性化抗生素治疗.
相关概念视频
01:20Pharmacokinetic Models: Overview
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...